BioSpace News Archive

I-Mab Biopharma and Jiangsu Nhwa Pharmaceutical announce on April 5th , 2019 that they have entered into collaborative research agreement with world-renowned scientists and clinicians at the Ann Romney Center for Neurologic Diseases at Brigham and Women’s Hospital and Biodextris, a Montreal-based biologics contract development and manufacturing organization, to jointly develop a novel immuno-stimulatory therapy for neurologic disorders by harnessing the natural power of the immune system.

CareCentrix, the leading provider of home-based post-acute care solutions, is selected as one of the Tampa region’s top employers, according to the Tampa Bay Times 2019 Top Workplaces ranking; over half of CareCentrix’s more than 800 Tampa region employees completed the survey.

Partnership Designed to Bring Improved Workflow to Radiation Oncology Departments

The deal aims to co-develop up to 4 ADCs including a novel ADC (Antibody-drug conjugate) that targets breast cancers expressing low levels of HER2 using iProgen’s proprietary antibody drug delivery technology.

Professor Fiona Wood, co-inventor of the RECELL System, described her experience treating more than 3,500 patients using RECELL and resulting benefits, including reduced time to healing and decreased length of hospitalization